Peters, C. J. http://orcid.org/0000-0003-2081-5701
Ang, Y. http://orcid.org/0000-0003-0496-6710
Ciccarelli, F. D. http://orcid.org/0000-0002-9325-0900
Coles, H.
Coleman, H. G.
Contino, G.
Crosby, T.
Devonshire, G.
Eldridge, M. http://orcid.org/0000-0002-5799-8911
Freeman, A. http://orcid.org/0000-0002-8376-7498
Grehan, N.
McCord, M.
Nutzinger, B.
Zamani, S. http://orcid.org/0000-0001-8622-5013
Parsons, S. L.
Petty, R.
Sharrocks, A. D.
Skipworth, R. J. E.
Smyth, E. C.
Soomro, I.
Underwood, T. J. http://orcid.org/0000-0001-9455-2188
Edwards, Paul A. W.
Redmond, Aisling M.
Loreno, Christine
Abbas, Sujath
O’Donovan, Maria
Miremadi, Ahmad
Malhotra, Shalini
Tripathi, Monika
Cheah, Calvin
Millington, Curtis
Secrier, Maria
Jammula, Sriganesh
Davies, Jim
Crichton, Charles
Carroll, Nick
Hardwick, Richard H.
Safranek, Peter
Hindmarsh, Andrew
Sujendran, Vijayendran
Hayes, Stephen J.
Preston, Shaun R.
Bagwan, Izhar
Save, Vicki
Hupp, Ted R.
O’Neill, J. Robert
Tucker, Olga
Beggs, Andrew
Taniere, Philippe
Puig, Sonia
Walker, Robert C.
Grace, Ben L.
Lagergren, Jesper
Gossage, James A.
Davies, Andrew R.
Chang, Fuju
Mahadeva, Ula
Goh, Vicky
Sanders, Grant
Berrisford, Richard
Chan, David
Cheong, Ed
Kumar, Bhaskar
Sreedharan, L.
Kaye, Philip
Saunders, John H.
Lovat, Laurence
Haidry, Rehan
Scott, Michael
Sothi, Sharmila
Lishman, Suzy
Hanna, George B.
Moorthy, Krishna
Grabowska, Anna
Turkington, Richard C.
McManus, Damian
Bartlett, Freddie
Fitzgerald, R. C. http://orcid.org/0000-0002-3434-3568
,
Funding for this research was provided by:
Cancer Research UK (RG81771/84119)
Article History
First Online: 19 December 2023
Competing interests
: Grant funding for OCCAMS infrastructure was provided by Cancer Research UK. Project specific funding for commercial assay technologies applied to OCCAMS samples was provided by Roche and Natera. R.F. is a shareholder in Cyted Ltd, an early diagnosis company.